Episode 1 of a 2-Part Series: “Sun Protection: A Review of Current Interventions and Barriers to Changing Patient Attitude and Behavior”
Photoprotection works, plain and simple. Yet all too often we must defend good science, dispel unfounded myths, and offer our first born children to get our patients to utilize sunscreen the right way when this behavior directly and primarily benefits them. Why is this and how do we airdrop knowledge in a meaningful way? In part one of this bonus two part podcast series dedicated to the science and psychology of sunscreen use, AAD Vice President Elect Neal Bhatia, MD joins host Adam Friedman, MD to slather on some practical approaches to communicating sunscreen science and real world use.
This enduring continuing education activity is supported by an independent medical education grant provided by Johnson & Johnson Consumer Inc. Participants who earn a minimum, passing grade of 70% would be eligible to receive up to 0.5 credit hours AMA PRA Category 1™ and ANCC credit per podcast. A total of 1 hour for this two-part Sun Protection series.
Upon completion of this enduring, internet-based series of continuing education activities, participants should be able to:
- Differentiate features, benefits and limits of chemical and physical sunblocking products
- Discuss the role of product formulation, delivery vehicle and patient type when recommending sun protection strategies
- Review multifunctional approaches to photoprotection including use of sunscreen-containing moisturizers and other skin care products
- Develop strategies leading to effective clinician-patient dialogues to better motivate patients to integrate regular use of sunscreens in their skin care regimen
Adam Friedman, MD – Grant/Research: Aclaris, CPN, Almirall. Consultant: SanovaWorks, Oakstone Institute, L’oreal, La Roche Posay, Galderma, Aveeno, Valeant, Microcures, Biogen, Pfizer, G&W Laboratories, Novartis, Occulus, Intraderm, Encore, Exeltis, Menlo, Lilly, Aclaris, Dermira, Berg, Allergan, Zylo Therapeutics, Hoth. Speaker’s Bureau: Regeneron, Dermira, Janssen, AbbVie. Major Stock Shareholder: Zylo, Minorcures.
Neal Bhatia, MD – Affiliations with Abbvie, Aclaris, Almirall, Biofrontera, BMS, BiopharmX, Dermira, Encore, EPI Health, Ferndale, Foamix, Galderma, Intraderm, ISDIN, J&J, LaRoche- Posay, Leo, Lilly, Mayne, Menlo, Novartis, Ortho, Pfizer, Pierre-Fabre, Regeneron, Sanofi, SkinFix, Soligenix, SunPharma, Vidac, and Vyome.